Abstract
This is the first report of Cushing's syndrome under oral budesonide treatment. An 81-year-old man known for paroxysmal atrial fibrillation and chronic renal insufficiency, treated with 6 mg budesonide for collagenous colitis, developed Cushing's syndrome under co-administration of amiodarone. The Cushing's syndrome disappeared after discontinuation of the amiodarone treatment. Metabolism of the two medications by hepatic cytochrome P 450 3A may explain the development of Cushing's syndrome.
MeSH terms
-
Aged
-
Aged, 80 and over
-
Amiodarone / therapeutic use
-
Anti-Arrhythmia Agents / therapeutic use
-
Anti-Inflammatory Agents / adverse effects*
-
Anti-Inflammatory Agents / therapeutic use
-
Atrial Fibrillation / drug therapy
-
Budesonide / adverse effects*
-
Budesonide / therapeutic use
-
Cushing Syndrome / chemically induced*
-
Cytochrome P-450 Enzyme System / metabolism
-
Humans
-
Male
Substances
-
Anti-Arrhythmia Agents
-
Anti-Inflammatory Agents
-
Budesonide
-
Cytochrome P-450 Enzyme System
-
Amiodarone